ArticleRevista brasileira de hematologia e hemoterapia

A Phase Ib open label, randomized, safety study of SANGUINATE™ in patients with sickle cell anemia.

Hemant Misra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.